• Loading content...
Fosun announces Gland buy

Fosun to buy KKR-backed Indian drugmaker for up to $1.3 bn

The largest inbound acquisition of an Indian company from abroad this year

Related: Shanghai Fosun to buy Gland Pharma for $1.4 bn

Shanghai Fosun Pharma halts share trading

Pharma sector receives Rs 4,975-cr FDI in FY16: Govt



Beyond liberalisation

Nitin Desai

The real challenge facing the Indian economy now is the restructuring of public institutions and regulatory systems

Central bank independence

A V Rajwade

What does India need more: growth and jobs, or low inflation?


Failures in defence

No respite from indigenisation delays, maintenance woes

Risky options

India not yet ready for options trading in commodities




Has Arvind Kejriwal gone too far by claiming he fears Narendra Modi might get him killed?

  • Yes
  • No
  • Can't Say


Most corporate tax breaks may be phased out in FY18

Tough to use tax rulings to your advantage

HC or tribunal verdicts aren't the final word in disputes, but you can use them to persuade the assessing officer


Inside Chennai's world of 3D illusions

Is 'glasses-free' 3D coming soon to a theater near you?

TV sets use a series of slits in front of screen that allow each eye to see a different set of pixels, creating a simulated sense of depth

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.

Premium Services

In Partnership with


Dear Guest,


Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard